Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Find Full text
Thumbnail
Fulltext:
152461.pdf
Embargo:
until further notice
Size:
726.6Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2015
Author(s)
Herwaarden, N. van
Bouman, C.A.M.
Maas, A. van der
Vollenhoven, R.F. van
Bijlsma, J.W.
Hoogen, F.H.J. van den
Broeder, A.A. den
Bemt, B.J.F van den
Source
Annals of the Rheumatic Diseases, 74, 12, (2015), pp. 2260-1
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/152461   https://hdl.handle.net/2066/152461
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.